Martha Larsen  |
Bringing scientific discoveries to patients
The Center for Chemical Genomics held a user forum on April 27 about practical issues for academic intellectual property . Martha Larsen, director of the HTS, siRNA, and HCS labs, puts the event in context.
Why is this subject important?
Intellectual property issues are of importance to any
researchers that hope to take their discoveries to benefit the public.
What is U-M's role in this?
The university is interested in technology transfer and
patents because they further the goal of the UM to give back to the society.
You don't have to be interested in starting a company to be concerned about
commercialization of your ideas and inventions. The
Office of Technology Transfer (OTT) at U-M assists researchers to make decisions about
disclosure of their discoveries (chemical, biological, materials) so that they
retain value for companies interested in potential therapeutics.
The OTT is there to help
navigate the waters of the legal and marketing aspects of your scientific
discoveries.
What does this have to do with research? Many researchers think that publishing a discovery is the
best way to get things to market and get companies interested and that is not
always true. This forum was to educate researchers about the rules about
technology transfer and the legal implications to academic activities like
posters, publications and other disclosures.
View the presenters' presentations from the event:
Matthew Bell presentation, OTT
David Casimir presentation, patent attorney Instructions on keeping a lab notebook
|
